2nd Quarter - Report

DLA PIPER LLP (US) for PFIZER, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare/Medicaid reimbursements.

LobbyistCovered position, as disclosed
TIMOTHY HOGAN —
MARY BETH LANGOWSKI —
EVAN M MIGDAIL —
PIPER NIETERS SU —
STEVEN R PHILLIPS —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Health Issues HCR

Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.

LobbyistCovered position, as disclosed
NICOLE CARELLI New —
MARY BETH LANGOWSKI —
EVAN M MIGDAIL —
PIPER NIETERS SU —
STEVEN R PHILLIPS —
JOHN SLOTMAN New LA/LD Rep Emerson; LA Rep Shuster; W&M Staff

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th), H.R. 5651 (112th), H.R. 3668 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.